Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MPO | P05164 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.53 |
| ▸ | MGAM | O43451 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | SI | P14410 | 3/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 3/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10079616 | 1.00 | MEN1 (0.56) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL30518932 | 1.00 | MEN1 (0.56) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL30518090 | 1.00 | MEN1 (0.56) | MEN1KMT2AMAPTKDM4ELMNA | |
| Hydrochloric Acid SCHEMBL11187822 | 0.98 | MEN1 (0.55) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL2870565 | 0.86 | ALDH1A1 (0.54) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL8234032 | 0.85 | GPR84 (0.53) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL10821238 | 0.85 | HTR2A (0.49) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL10332616 | 0.85 | HTR2A (0.49) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL4170824 | 0.83 | MAPT (0.54) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL4184199 | 0.83 | MAPT (0.54) | MEN1KMT2AMAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12465660-B2 | Compositions and methods for cancer imaging and radiotherapy | VECT-HORUS (FR) | 2025-11-11 | — | — | US | disclosed |
| US-20240100204-A1 | COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY | VECT-HORUS (FR) | 2024-03-28 | — | — | US | disclosed |
| US-11712486-B2 | Compositions and methods for cancer imaging and radiotherapy | VECT-HORUS (FR) | 2023-08-01 | — | — | US | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-110452151-B | Synthetic method of alpha-indole glycine derivative | 江苏科技大学 | 2022-12-30 | — | — | CN | disclosed |
| US-20190351079-A1 | COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY | VECT-HORUS (FR) | 2019-11-21 | — | — | US | disclosed |
| EP-2908837-B1 | COMPOSITIONS FOR DRUG DELIVERY | VECT HORUS (FR) | 2019-02-13 | — | — | EP | disclosed |
| WO-2018138372-A1 | COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY | VECT-HORUS (FR) | 2018-08-02 | — | — | WO | disclosed |
| EP-2547692-B1 | PEPTIDE DERIVATIVES, PREPARATION THEREOF AND USES THEREOF AS VECTORS | VECT-HORUS (FR) | 2017-05-17 | — | — | EP | disclosed |
| US-5245046-A | α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | THE UPJOHN COMPANY (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0375133-A1 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | THE UPJOHN COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0375133-A1 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | THE UPJOHN COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0375133-A1 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | THE UPJOHN COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
| WO-1990005721-A1 | ALPHA-AMINO-INDOLE-3-ACETIC ACIDS USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS | THE UPJOHN COMPANY (US) | 1990-05-31 | — | — | WO | disclosed |
| WO-1990005721-A1 | ALPHA-AMINO-INDOLE-3-ACETIC ACIDS USEFUL AS ANTI-DIABETIC, ANTI-OBESITY AND ANTI-ATHEROSCLEROTIC AGENTS | THE UPJOHN COMPANY (US) | 1990-05-31 | — | — | WO | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0073143-B1 | NOVEL COMPLEX AMIDO AND IMIDO DERIVATIVES OF CARBOXYALKYL PEPTIDES AND THIOETHERS AND ETHERS OF PEPTIDES | Ryan, James Walter (US) | 1985-11-21 | — | — | EP | disclosed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | PAICS, LNPEP, DNPEP | MEN1 58/4885KMT2A 1875/4885MAPT 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.